Skip to main content
Log in

The physical ability of elderly female Japanese patients with cerebrovascular disease correlates with telomere length in their peripheral blood leukocytes

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background and aims: The telomere length of peripheral blood leukocytes has been reported to be inversely correlated with many kinds of pathophysiological conditions. However, correlations between telomere length in peripheral blood leukocytes and patients’ physical ability are not known. Methods: To address this problem, the physical ability of patients with cerebrovascular disease admitted to the chronic disease ward of Kyushu University Hospital was assessed with the Barthel index (BI) and the telomere length of their peripheral blood leukocytes was determined. Results and conclusions: Women exhibited a significant correlation between the Barthel score and the expression of long telomeres (>9.4 Kb), in contrast with men who revealed no such correlation. The physical ability of older women was positively correlated with the lengths of their somatic telomeres. Among the BI items, the scores of more difficult physical performances tended to correlate with the presence of terminal restriction fragments longer than 9.4 Kb.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000; 34: 331–58.

    Article  CAS  PubMed  Google Scholar 

  2. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339–44.

    Article  Google Scholar 

  3. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 842–6.

    Article  CAS  PubMed  Google Scholar 

  4. Ogami M, Ikura Y, Ohsawa M et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004; 24: 546–50.

    Article  CAS  PubMed  Google Scholar 

  5. Uziel O, Singer JA, Danicek V et al. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp Gerontol 2007; 42: 971–8.

    Article  CAS  PubMed  Google Scholar 

  6. Panossian LA, Porter VR, Valenzuela HF et al. Telomere shortening in T cells correlates with Alzheimer’s disease status. Neurobiol Ageing. 2003; 24: 77–84.

    Article  CAS  Google Scholar 

  7. Valdes AM, Andrew T, Gardner JP et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662–4.

    Article  CAS  PubMed  Google Scholar 

  8. Epel ES, Blackburn EH, Lin F et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004; 101: 17312–5.

    Article  CAS  PubMed  Google Scholar 

  9. Guan JZ, Maeda T, Sugano M et al. A Percentage analysis of the telomere length in Parkinson’s disease patients. J Gerontol A Biol Sci Med Sci 2008; 63A: 467–73.

    Article  CAS  Google Scholar 

  10. Guan JZ, Maeda T, Sugano M, et al. An analysis of telomere length in sarcoidosis. J Gerontol A Biol Sci Med Sci 2007; 62: 1199–203.

    Article  PubMed  Google Scholar 

  11. Cawthon RM, Smith KR, O’Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393–5.

    Article  CAS  PubMed  Google Scholar 

  12. Guan JZ, Maeda T, Sugano M, Oyama J, Higuchi Y, Makino N. Change in the telomere length distribution with age in the Japanese population. Mol Cell Biochem 2007; 304: 253–60.

    Article  Google Scholar 

  13. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61–5.

    CAS  PubMed  Google Scholar 

  14. Maeda T, Guan JZ, Oyama J, Higuchi Y, Makino N. Age-related changes in subtelomeric methylation in the normal Japanese population. J Gerontol A Biol Sci Med Sci 2009; 64: 426–34.

    Article  PubMed  Google Scholar 

  15. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis Circ Res 2007; 100: 460–73.

    Article  CAS  PubMed  Google Scholar 

  16. Kyo S, Takakura M, Kanaya T et al. Estrogen activates telomerase. Cancer Res 1999; 59: 5917–21.

    CAS  PubMed  Google Scholar 

  17. Chao HH, Chen JJ, Chen CH et al. Inhibition of angiotensin II induced endothelin-1 gene expression by 17oestradiol in rat cardiac fibroblasts. Heart 2005; 91: 664–9.

    Article  CAS  PubMed  Google Scholar 

  18. Dantas AP, Tostes RC, Fortes ZB, Costa SG, Nigro D, Carvalho MH. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002; 39: 405–11.

    Article  CAS  PubMed  Google Scholar 

  19. Dean SA, Tan J, O’Brien ER, Leenen FH. 17-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol 2005; 288: R759–66.

    Article  Google Scholar 

  20. Florian M, Freiman A, Magder S. Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 2004; 69: 779–87.

    Article  CAS  PubMed  Google Scholar 

  21. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NADPH oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 38–44.

    Article  CAS  PubMed  Google Scholar 

  22. Laufs U, Adam O, Strehlow K et al. Down-regulation of Rac-1 GTPase by estrogen. J Biol Chem 2003; 95: 5956–62.

    Article  Google Scholar 

  23. Strehlow K, Rotter S, Wassmann S et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003; 93: 170–7.

    Article  CAS  PubMed  Google Scholar 

  24. Wagner AH, Schroeter MR, Hecker M. 17-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 2001; 15: 2121–30.

    Article  CAS  PubMed  Google Scholar 

  25. Wassmann S, Baumer AT, Strehlow K et al. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 2001; 103: 435–41.

    Article  CAS  PubMed  Google Scholar 

  26. Tang M, Subbiah MTR. Estrogens protect against hydrogen peroxide and arachidonic acid induced DNA damage. Biochim Biophys Acta 1996; 1299: 155–9.

    Article  PubMed  Google Scholar 

  27. Hernandez-Ono A, Monter-Carreola G, Zamora-Gonzalez J et al. Association of visceral fat with coronary risk factors in a population- based sample of postmenopausal women. Int J Obes Relat Metab Disord 2002; 26: 33–9.

    Article  CAS  PubMed  Google Scholar 

  28. You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004; 89: 5517–22.

    Article  CAS  PubMed  Google Scholar 

  29. Tchernof A, Poehlman ET. Effects of the menopause transition on body fatness and body fat distribution. Obes Res 1998; 6: 246–54.

    Article  CAS  PubMed  Google Scholar 

  30. Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obes Res 2002; 10: 1203–6.

    Article  PubMed  Google Scholar 

  31. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effects of the menopause transition on insulin sensitivity secretion and elimination in non-obese healthy women. Eur J Clin Invest 1993; 23: 466–73.

    Article  CAS  PubMed  Google Scholar 

  32. Witteman J, Grobbee D, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after menopause. BMJ 1989; 298: 642–4.

    Article  CAS  PubMed  Google Scholar 

  33. Yasumizu T, Okuno T, Fukada Y, Hoshi K. Age-related changes in bone mineral density and serum bone-related proteins in premenopausal and postmenopausal Japanese women. Endocr J 2000; 47: 103–9.

    Article  CAS  PubMed  Google Scholar 

  34. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–37.

    Article  CAS  PubMed  Google Scholar 

  35. Sowers MR, La Pietra MT. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev 1995; 17: 287–302.

    CAS  PubMed  Google Scholar 

  36. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984; 63: 759–63.

    CAS  PubMed  Google Scholar 

  37. Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178–208.

    CAS  PubMed  Google Scholar 

  38. Valdes AM, Richards JB, Gardner JP et al. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int 2007; 18: 1203–10.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toyoki Maeda MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maeda, T., Oyama, Ji., Sasaki, M. et al. The physical ability of elderly female Japanese patients with cerebrovascular disease correlates with telomere length in their peripheral blood leukocytes. Aging Clin Exp Res 23, 22–28 (2011). https://doi.org/10.1007/BF03324949

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324949

Navigation